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Abstract
Background: The optimal treatment of displaced femoral neck fractures in patients over 60 years is controversial.
While much research has focused on the impact of total hip arthroplasty (THA) and hemiarthroplasty (HA) on
surgical outcomes, little is known about patient preferences for either alternative. The purpose of this study was to
elicit surgical preferences of patients at risk of sustaining hip fracture using a novel decision board.
Methods: We developed a decision board for the surgical management of displaced femoral neck fractures
presenting risks and outcomes of HA and THA. The decision board was presented to 81 elderly patients at risk for
developing femoral neck fractures identified from an osteoporosis clinic. The participants were faced with the
scenario of sustaining a displaced femoral neck fracture and were asked to state their treatment option preference
and rationale for operative procedure.
Results: Eighty-five percent (85%) of participants were between the age of 60 and 80 years; 89% were female; 88%
were Caucasian; and 49% had some post-secondary education. Ninety-three percent (93%; 95% confidence interval
[CI], 87-99%) of participants chose THA as their preferred operative choice. Participants identified several factors
important to their decision, including the perception of greater walking distance (63%), less residual pain (29%),
less reoperative risk (28%) and lower mortality risk (20%) with THA. Participants who preferred HA (7%; 95% CI, 1-
13%) did so for perceived less invasiveness (50%), lower dislocation risk (33%), lower infection risk (33%), and
shorter operative time (17%).
Conclusion: The overwhelming majority of patients preferred THA to HA for the treatment of a displaced femoral
neck fracture when confronted with risks and outcomes of both procedures on a decision board.
Background
Hip fractures are suffered by 280, 000 Americans and
36, 000 Canadians annually [1]. As the population of
those aged 65 years or older in North America will rise
from 34.8 to 77.2 million by 2040, the incidence of hip
fractures is expected to exceed 500, 000 and 88, 000 in
the United States and Canada respectively [1]. This
increased incidence will correspondingly have an
exhaustive economic toll, as health care costs surround-
ing hip fracture care will reach $9.8 billion in the United
States and $650 million in Canada [1,2].
The optimal treatment of femoral neck fractures
depends on a multitude of factors including the degree
of fracture displacement and patient’s age, risk profile,
functional demands, cognitive function and physical fit-
ness [3,4]. Three surgical options are available for such
fractures: internal fixation, hemiarthroplasty (HA), and
total hip arthroplasty (THA) [5,6]. Hemiarthroplasty is
the treatment of choice in low-demand and cognitively
impaired elderly patients [5]. However, the ideal man-
agement of displaced femoral neck fractures in relatively
healthy, independent and lucid patients over the age of
60 years remains controversial [5,7]. Most orthopedic
surgeons favour arthroplasty over internal fixation [5].
Recent studies have also demonstrated that arthroplasty
produces superior functional results relative to internal
fixation and is therefore preferable for this patient
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surgeons as to whether HA or THA is optimal, with
most surgeons favouring HA [5,11]. Proponents of HA
quote the advantages of a shorter and simpler surgical
procedure, reduced risk of dislocation and the decreased
component costs. On the other hand, advocates of THA
criticize HA since it results in rapid wear of the acetab-
ular articular cartilage and emphasize that THA is asso-
ciated with improved functional outcomes, lower
postoperative pain scores and potential decrease in reo-
peration rates [7,9,10,12-16].
When varying treatment options exist favouring differ-
ent outcomes and risks, which may be valued differently
by patients and physicians, it becomes critical to incor-
porate and rely on patients’ preferences in recommend-
ing treatment options [17]. Moreover, information
regarding the different surgical options and their out-
comes should be delivered to patients in a thorough,
consistent and unbiased manner [18]. Decision aids can
be invaluable resources to aid surgeons in this commu-
nication task. Decision aids are “tools designed to help
people participate in decision making about health care
options” [19]. They provide clear information on the
treatment options as well as their risks and benefits and
thus assist patients clarify and communicate the perso-
nal value they associate with different features of the
options [19].
Despite the controversy surrounding hip fracture care,
the orthopaedic literature is void of studies eliciting
patient’s preferences and detailing the effectiveness of
decision aids to inform patients of hip fracture manage-
ment [20]. The purpose of this study was to utilize a
decision board to elicit surgical preferences for treat-
ment of displaced femoral neck fractures from patients
at risk for sustaining this fracture.
Methods
Decision aid development
We developed an electronic decision board following
accepted decision board development methods [21-25].
The decision tool fulfilled the CREDIBLE criteria for
assessing decision tool quality [26].
The contents of the decision board were abstracted
from a systematic review conducted to identify all ran-
domized controlled trials comparing HA and THA for
the treatment of displaced femoral neck fractures in
patients over the age of 60 years. We searched articles
using MEDLINE and EMBASE from 1966 to January
2007. No language restrictions were applied. The biblio-
graphies of all retrieved publications were reviewed for
additional relevant articles. The article titles and
abstracts were then assessed to ensure that the study
was a randomized trial involving the treatment of dis-
placed femoral neck fractures with HA or THA. The
data abstracted from the eligible studies consisted of
interventions, duration of surgery, functional outcomes
and rates of complications (infections, dislocations, med-
ical complications, reoperations and mortality).
Five randomized controlledt r i a l sm e tt h ei n c l u s i o n
criteria [9,10,16,27,28]. The paper by Ravikumar [9]
represents a 13-year follow-up of the Skinner trial [10]
and therefore it was not used for our data abstraction.
The results of the remaining 4 studies were pooled
across studies using estimates from individual trials
weighted based on sample size to produce the data pre-
sented in the electronic decision aid (Table 1).
T h ei n f o r m a t i o ni n c l u d e di nt h ee l e c t r o n i cd e c i s i o n
board (Figure 1) was based on a previously developed
orthopedic decision board addressing treatment options
for displaced femoral neck fractures [29]. This informa-
tion included a background about femoral neck frac-
tures, a description of the two treatment options [30]
(HA and THA) and their respective outcomes and risks.
We used the terms “metallic ball” and “metallic ball and
socket” to avoid bias by introducing the words “hemi/
partial” and “total”. We presented the outcomes as prob-
abilities using the phrase, “Out of 100 patients who will
have this procedure, a certain number will develop the
complication indicated.”
Decision boards have been extensively tested in multi-
ple medical fields including orthopedic surgery, and
shown to be valid, reliable and easily administered tools
[21,31,32]. We were confident in the reliability of this
decision board given our previous evaluation of a similar
decision board on femoral neck fractures [29].
Participants
Approval was obtained from the local research ethics
board for the study. Participants were recruited from an
osteoporosis clinic. Participants were all independent,
competent and over the age of 60 years. This population
was selected as the study subjects because older patients
with osteoporosis would represent a high-risk group to
suffer femoral neck fractures [14,33-38].
Participants were excluded if they were incompetent
cognitively or if they had a previous hip fracture or
replacement, since their choice could be biased towards
or against the treatment option they previously received.
Patients arriving at the osteoporosis clinic were screened
for eligibility; if they met the criteria, then they were
asked to participate and included in the study if they
provided consent.
Decision board administration
The decision board was administered to participants by
two of the authors (N.A. and R.M.). After the board was
developed, a guideline outlining what and how informa-
tion would be presented was established between the
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tered the decision board to each other to ensure consis-
tency in the way the interview was conducted.
Participants were presented with the following
hypothetical scenario: “While walking, you slip on ice
and fall down. You are taken to the nearest hospital and
after careful physical and radiographic examination, you
are found to have a femoral neck fracture (a fracture of
the long thigh bone at the hip level). The orthopedic
surgeon tells you that there are two treatment options
for this type of fracture.” The decision board was then
presented to the participants, who read each part of the
decision board independently. Questions were encour-
aged at any time during the interview to clarify vague
information or address any concerns. All questions were
answered ensuring that the interviewers elicited no bias.
Participants’ stated their preferences for treatment and
the strength of their choice using a 7-point adjectival
scale (1–I definitely prefer metallic ball and socket; 4–I
am indifferent; 7–I definitely prefer metallic ball). They
were then asked for the primary reasons of their treat-
ment option choice.
Demographic and satisfaction questionnaire
At the end of the interview, the participants completed a
questionnaire on socio-demographic variables (gender,
Table 1 Derivation of the pooled data used in the
decision board based on the outcomes from the included
clinical trials
Outcomes THA HA
Operative Time
Keating 80 59
Dorr - -
Baker 93 78
Skinner - -
Pooled Data 87 min 69 min
Post-operative Walking Distance
Keating - -
Dorr - -
Baker 3.6 Km 1.9 Km
Skinner - -
Pooled Data 3.6 Km 1.9 Km
Residual Pain
Keating 29/61 30/60
Dorr - -
Baker - -
Skinner 0/62 20/73
Pooled Data 29/123 (24%) 50/133 (38%)
Failure to Regain Mobility
Keating - -
Dorr 7/39 15/50
Baker - -
Skinner 13/62 11/73
Pooled Data 20/101 (20%) 26/123 (21%)
Dislocation
Keating 3/69 2/69
Dorr 7/39 2/50
Baker 3/40 0/41
Skinner 10/80 11/100
Pooled Data 23/228 (10%) 15/260 (6%)
Medical Complications
Keating 14/69 12/69
Dorr - -
Baker 1/40 3/41
Skinner - -
Pooled Data 15/109 (14%) 15/110 (14%)
Superficial Wound Infection
Keating 2/69 2/69
Dorr 0/39 0/50
Baker 2/40 1/41
Skinner - -
Pooled Data 4/148 (3%) 3/160 (2%)
Deep Wound Infection
Keating 1/69 1/69
Dorr 0/39 0/50
Table 1 Derivation of the pooled data used in the deci-
sion board based on the outcomes from the included
clinical trials (Continued)
Baker 1/40 0/41
Skinner 1/80 0/100
Pooled Data 3/228 (1%) 1/260 (0%)
Reoperation within 1 year
Keating 6/69 5/69
Dorr 9/39 6/50
Baker 1/40 6/41
Skinner 13/80 24/100
Pooled Data 29/228 (13%) 41/260 (16%)
3-4 month Mortality
Keating 2/69 5/69
Dorr - -
Baker - -
Skinner 8/80 15/100
Pooled Data 10/149 (7%) 20/169 (12%)
1 year Mortality
Keating 4 6
Dorr - -
Baker - -
Skinner 18 27
Pooled Data 22/149 (15%) 33/169 (20%)
Alolabi et al. BMC Musculoskeletal Disorders 2011, 12:289
http://www.biomedcentral.com/1471-2474/12/289
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previous history of fractures, and an evaluation for the
acceptability and satisfaction of using the decision board
as a tool to inform patients about treatment options.
Acceptability of the decision board was assessed by
asking questions regarding how well they understood
the board, its usefulness in helping them make a deci-
sion, and whether they would recommend it for others.
Satisfaction was assessed with respect to the amount of
information provided, the use of the decision board as a
Figure 1 An Illustration of the decision board.
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sion-making tool.
Data analysis
For each study, we calculated the means differences for
continuous outcomes. When possible, we pooled the
estimates from individual trials based on sample size.
Group data were summarized in terms of frequency and
percentage (with 95% confidence intervals). With
approximately 70% of participants choosing one surgical
option, we determined that a sample size of 80 would
be needed for a 95% confidence interval +/-10%.
Results
Between May 2008 and May 2009, we screened partici-
pants in the osteoporosis clinic for eligibility. Eight-four
participants met eligibility criteria and were recruited.
Three participants were omitted from the study post-
interview; one had Alzheimer’s disease and two did not
understand English well. Data was therefore collected
and analyzed for 81 participants.
Eighty-five percent (85%) of participants were between
the age of 60 and 80 years; 89% were female; 88% were
Caucasian; and 49% had some post-secondary education
(Table 2). By far, the majority of participants had a
documented diagnosis of osteoporosis. The remainder
minority had predisposing factors putting them at a
high risk for developing osteoporosis.
Of 81 participants, 75 (93%; 95% confidence intervals
[CI], 87-99) chose THA as their preferred treatment
option. The main factors contributing to this choice
included the perception of ability to walk a greater dis-
tance (63%; CI, 52-74), less residual pain (29%; CI, 19-
39), lower reoperative risk (28%; CI, 18-28), and lower
mortality (20%; CI, 11-29) (Figure 2). Participants who
chose HA (7%; CI, 1-13) as their preferred treatment
choice cited less invasiveness (50%; CI, 39-61), less dis-
location (33%; CI, 23-43), less infection (33%; CI, 23-43),
and shorter operative time (17%; CI, 9-25) (Figure 3).
The majority of those who chose THA were quite com-
fortable with their preference as indicated by their
strength of choice, whereas the majority of those who
chose HA were closer to being indifferent (Figure 4).
All participants completed the acceptability and satis-
faction questionnaire. Ninety-eight percent (98%; CI, 95-
101) of participants stated that the decision board was
easy to understand, 96% (CI, 92-100) reported that it
helped them make a decision, and 96% (CI, 92-100)
indicated that they would recommend the use of the
decision board to others. Furthermore, 100%, 97% (CI,
93-101) and 97% (CI, 93-101) of participants were satis-
fied with the decision board as a method for presenting
information, the amount of information presented, and
the use of the decision board as a decision-making tool
respectively (Figure 5).
Discussion
This decision board analysis demonstrates that the over-
whelming majority of participants preferred total hip
arthroplasty to hemiarthroplasty for the treatment of
displaced femoral neck fractures in patients over 60
years. The main contributing factors for this preference
Table 2 Participants’ Demographics
Demographic Category THA (n = 75) HA (n = 6) Total (n = 81)
Gender Male 6 (8%) 3 (50%) 9 (11%)
Female 69 (92%) 3 (50%) 72 (89%)
Age 60-70 y.o 38 (51%) 1 (17%) 39 (48%)
70-80 y.o 27 (36%) 3 (50%) 30 (37%)
80-90 y.o 9 (12%) 2 (33%) 11 (14%)
> 90 y.o 1 (1%) 0 (0%) 1 (1%)
Race White or Caucasian 67 (89%) 4 (67%) 71 (88%)
Asian 1 (1%) 0 (0%) 1 (1%)
Black 2 (3%) 0 (0%) 2 (2%)
South Asian 2 (3%) 1 (17%) 3 (4%)
Other 3 (4%) 1 (17%) 4 (5%)
Education Level High School 28 (37%) 2 (33%) 30 (37%)
Post-Secondary 38 (51%) 2 (33%) 40 (49%)
Other 9 (12%) 2 (33%) 11 (14%)
Income (n = 55 for THA, 5 for HA and 60 for Total) $0-$40, 000 31 (56%) 5 (100%) 36 (60%)
$40, 000-$80, 000 24 (44%) 0 (0%) 24 (40%)
> $80, 000 0 (0%) 0 (0%) 0 (0%)
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dual pain, and reduced risk of reoperation. Interestingly,
most orthopedic surgeons have the opposite preference;
an international survey by Bhandari et al. as well as a
survey administered to the American Association of Hip
and Knee Surgeons both illustrated that 80-85% of sur-
geons favor hemiarthroplasty over total hip arthroplasty
for the treatment of displaced femoral neck fractures in
patients over 60 years [5,11].
Our findings demonstrate a substantial discrepancy
between patient and surgeon preferences for the treat-
ment of displaced femoral neck fractures. Other studies
have demonstrated that there is a gap between patient
and physician preferences [39,40]. For example, com-
pared to physicians, patients are willing to accept a
much higher bleeding risk for an associated reduction in
risk of stroke [39], and cancer patients are willing to
accept treatment with severe side effects for a much
smaller chance of improvement [40]. It is therefore
important for clinicians not to assume their patients’
preference and to ensure that their patients are well
informed about treatment options in an unbiased
manner.
Involving patients in the decision-making process is
the focus of patient-centered care. Studies have revealed
that involving patients in their care changes patient
behavior and increases compliance with treatment
[41,42]. Decision aids can be invaluable resources, assist-
ing physicians to relay unbiased information to patients
during this shared decision-making process [18,20]. A
systematic review of 55 randomized controlled trials
evaluating the efficacy of decision aids compared to no
aid, usual care, or an alternative intervention, illustrated
that patients who used a decision aid were more satis-
fied and had greater knowledge and less decisional con-
flict relative to patients in the other groups [26]. In our
study, the majority of patients found the decision board
easy to understand, enabled them to make a decision
and were satisfied with it as a method to present infor-
mation and as a decision making tool.
A tt h et i m eo ft h eo n s e to fo u rs t u d y ,o n l yt h et r i a l s
included in our study were published. However, there
have been a number of trials and reviews published
since then, most favoring THA over HA [8,12-14,43,44]
and others showing no advantage of THA over HA and
thus favoring HA [45]. Although we acknowledge that
these new studies may affect the results of our study,
however, most studies still demonstrate similar trends to
our decision board. Since the controversy regarding
THA and HA for the treatment of displaced femoral
neck fractures still exists, eliciting patients’ preferences
is important.
The treatment choices presented to the participants in
our study included HA and THA. A non-operative
approach was not included since it is restricted to a very
narrow patient group with significant medical conditions
preventing them from operative treatment. Similarly,
Figure 4 Patients’ Strength of Choice.
Figure 2 Patients’ Cited Reasons for Preferring THA.
Figure 3 Patients’ Cited Reasons for Preferring HA.
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previously performed a similar study eliciting treatment
preferences between internal fixation and hemiarthro-
plasty [29].
Our study has several strengths. We followed rigorous,
well-defined methodology to develop the decision aid.
We used one-on-one interviews to ensure that all parti-
cipants understood the questions being asked and pro-
vided their true preferences. All participants were above
60 years and 85% of them were between the ages of 60
and 80–the main controversial age group for treatment
of these fractures. Furthermore, the patients were
recruited from an osteoporosis clinic and had no pre-
vious history of hip fracture, which made them a high-
risk population for intracapsular hip fractures yet
a v o i d e db i a s e ss u c ha sc h r o n i cp a i ns e c o n d a r yt o
osteoarthritis or a prior hip replacement with HA or
THA.
The main limitation of this study is the study popula-
tion. Ideally we would have involved real patients with
displaced intracapsular hip fractures at the point of deci-
sion-making. However, this task is a challenging one
since most surgeons often have strong preferences about
the appropriate treatment modality of individual patients
[13]. Also, at our institution, and many other institu-
tions, THA is performed only by specially trained
arthroplasty surgeons, who represent a small portion of
surgeons treating acute femoral neck fractures. Hence,
we could not administer the decision board and elicit
preferences in actual hip fracture patients since it would
not be possible or practical to offer all patients THA if
they chose it as their preferred treatment option. How-
ever, the study population we studied was perhaps the
closest to real patients. The typical patient presenting
with a femoral neck fracture is a woman over 60 years
with osteoporosis and other comorbidities [14,33-38].
Osteoporosis and prior fragility fractures are the most
significant risk factors for hip fracture. Many other risk
factors including age, female sex, family history of frac-
tures and body mass are indirect measures or risk fac-
tors of osteoporosis [34]. We chose independent and
competent patients over the age of 60 years who were at
an osteoporosis clinic either for treatment of a docu-
mented diagnosis of osteoporosis or a condition predis-
posing them to develop osteoporosis. Also, most of our
patients were females. Therefore, we believe that this
patient population is highly representative of actual
independent and relatively active patients with an intra-
capsular hip fracture. Another limitation is the fact that
newer trials comparing THA and HA are not included
in the decision board data but, as mentioned, these stu-
dies were not published at the time of onset of this
study.
Conclusion
The overwhelming majority of patients prefer THA to
HA for the treatment of displaced femoral neck frac-
tures, despite the current trend of surgeons to favor
HA over THA. Surgeons should discuss the advantages
and disadvantages of each approach with individual
patients and involve them in a shared decision-making
process. Decision aids may be helpful to surgeons in
Figure 5 Patients’ Acceptability and Satisfaction with the Decision Board.
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Page 7 of 9this process, as well as other areas of surgical
management.
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